SAM
RPRX icon

Simplify Asset Management’s Royalty Pharma RPRX Stock Holding History

Simplify Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-94,066
Closed -$2.66M – 120
2024
Q3 		$2.66M Buy
94,066
+37,878
+67% +$1.05M 0.12% 46
2024
Q2 		$1.48M Sell
56,188
-92,267
-62% -$2.56M 0.1% 58
2024
Q1 		$4.51M Buy
+148,455
New +$4.38M 0.27% 30

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplify Asset Management's RPRX Position: Q4 2024 in Review

Simplify Asset Management sold out of Royalty Pharma (RPRX) in Q4 2024, closing a stake of 94,066 shares — an estimated $2.66M sold.

Simplify Asset Management first reported a position in RPRX in Q1 2024 and held it in 3 quarters. The position peaked at $4.51M in Q1 2024. 417 funds tracked by Wall St. Rank hold RPRX as of Q4 2024.

  • Simplify Asset Management reported no remaining Royalty Pharma position as of Q4 2024 after selling out during the quarter.
  • Simplify Asset Management sold 94,066 Royalty Pharma shares in Q4 2024, an estimated $2.66M.
  • Simplify Asset Management first reported a position in Royalty Pharma in Q1 2024 and held it in 3 quarters.
  • Simplify Asset Management's Royalty Pharma position peaked at $4.51M in Q1 2024.
  • 417 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2024.

Based on Simplify Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.